Impact of STAT1 polymorphisms on crizotinib-induced hepatotoxicity in ALK-positive non-small cell lung cancer patients
Shuang Xin, Wenfeng Fang, Jianwen Li, Delan Li, Changzheng Wang, Quanfei Huang, Min Huang, Wei Zhuang, Xueding Wang, Likun Chen
Topics & Concepts
CrizotinibCancer researchALK inhibitorLung cancerMAPK/ERK pathwayWnt signaling pathwayAnaplastic lymphoma kinaseBiologyMedicineInternal medicineOncologySignal transductionPharmacologyGeneticsMalignant pleural effusionLung Cancer Treatments and MutationsFibroblast Growth Factor ResearchRadiomics and Machine Learning in Medical Imaging